BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29

• Press Releases

  Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025

  July 28, 2025

   · 

  1 min read
• Press Releases

  Exelixis Announces Second Quarter 2025 Financial Results and Provides Corporate Update

  July 28, 2025

   · 

  20 min read
• Press Releases

  Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights

  July 28, 2025

   · 

  9 min read
• Press Releases

  Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

  July 28, 2025

   · 

  2 min read
• Press Releases

  Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025

  July 28, 2025

   · 

  1 min read
• Press Releases

  AVITA Medical to Announce Second Quarter 2025 Financial Results

  July 28, 2025

   · 

  2 min read
• Press Releases

  Roivant to Report Financial Results for the First Quarter Ended June 30, 2025, and Provide Business Update on Monday, August 11, 2025

  July 28, 2025

   · 

  4 min read
• Press Releases

  Filgotinib Shows Positive Topline Results Across Full Spectrum of Axial Spondyloarthritis in OLINGUITO Phase 3 Study

  July 28, 2025

   · 

  9 min read
• Press Releases

  AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference

  July 28, 2025

   · 

  1 min read
• Press Releases

  Avidity Biosciences Announces Completion of Enrollment for HARBOR™, the First Global Phase 3 Trial of Delpacibart Etedesiran (del-desiran) for Treatment of DM1 and Provides Guidance on Regulatory Submission

  July 28, 2025

   · 

  8 min read